Proteomics of dedifferentiation of SK-N-BE2 neuroblastoma cells

• DOI: 10.1016/j.bbrc.2014.10.065
• Publication Date: 2014-10-18T05:47:53Z
• Authors: Ravi Kanth Rao Saini; Sanaz Attarha; Claire da Silva S...; Justyna Kolakowska; Keiko Funa; Serhiy Souchelnyt...
• Keywords: Proteomics; 0301 basic medicine; Proteome; Nuclear Proteins; Nerve Tissue Proteins; DNA-Activated Protein Kinase; Cell Dedifferentiation; Mass Spectrometry; Neoplasm Proteins; 3. Good health; Neuroblastoma; 03 medical and health sciences; Neural Stem Cells; Tissue Array Analysis; Cell Line, Tumor; Spheroids, Cellular; Biomarkers, Tumor; Neoplastic Stem Cells; Humans; Protein Interaction Maps

Neuroblastoma develops through processes which include cellular dedifferentiation. Ability of tumors to form spheroids is one of the manifestations of dedifferentiation and carcinogenic transformation. To study mechanisms of dedifferentiation of neuroblastoma cells, we generated spheroids and performed a proteomics study to compare the spheroids with parental SK-N-BE2 cells. We observed that dedifferentiation induced extensive changes in the proteome profiles of the cells, which affected more than 30% of detected cellular proteins. Using mass spectrometry, we identified 239 proteins affected by dedifferentiation into spheroids as compared to the parental cells. These proteins represented such regulatory processes as transcription, cell cycle regulation, apoptosis, cell adhesion, metabolism, intracellular transport, stress response, and angiogenesis. A number of potent regulators of stemness, differentiation and cancer were detected as subnetworks formed by the identified proteins. Our validation tissue microarray study of 30 neuroblastoma cases confirmed that two of the identified proteins, DISC1 and DNA-PKcs, had their expression increased in advanced malignancies. Thus, our report unveiled extensive changes of the cellular proteome upon dedifferentiation of neuroblastoma cells, indicated top subnetworks and clusters of molecular mechanisms involved in dedifferentiation, and provided candidate biomarkers for clinical studies.